IMPLEMENTING A VIRTUAL NEPHROLOGY PANEL FOR TOLVAPTAN USE IN PATIENTS WITH ADPKD

被引：0
|
作者：
Lin Duong [1 ]
Taneja, Nidhika [1 ]
Belani, Sharina [1 ]
Irannejad, Pardis [1 ]
Jain, Anagha [1 ]
Lieberman, Jonathan [1 ]
Tuan Nguyen [1 ]
Ramaswamy, Deepa [1 ]
机构：
[1] Kaiser Permanente Northern Calif, Oakland, CA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2021年 / 77卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
75
引用
收藏
页码：590 / 590
页数：1
相关论文
共 50 条
  • [31] BOTH HYDROCHLOROTHIAZIDE AND METFORMIN AMELIORATE AQUARETIC SIDE-EFFECTS IN ADPKD PATIENTS THAT ARE TREATED WITH TOLVAPTAN
    Kramers, Bart
    Koorevaar, Iris
    Aapkes, Sophie
    Dekkers, Claire
    Heerspink, Hiddo Lambers
    Gansevoort, Ronald
    Meijer, Esther
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1 - 1
  • [32] EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE STAGE CKD
    Hattanda, Fumihiko
    Nishio, Saori
    Takeda, Sayo
    Atsumi, Tatsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [33] EVALUATION OF THE EFFECT OF TOLVAPTAN ON OXIDATIVE STRESS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Rigato, Matteo
    Bertoldi, Giovanni
    Ravarotto, Verdiana
    Carraro, Gianni
    Calo, Lorenzo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [34] ALL-CAUSE DISCONTINUATION OF TOLVAPTAN IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): A SECONDARY USE OF DATA ANALYSIS OF PATIENTS IN THE IMADJIN DATASET
    Thomas, M.
    Gois, P. H. Franca
    Butcher, B. E.
    Ta, M.
    Van Wyk, G.
    NEPHROLOGY, 2020, 25 : 63 - 63
  • [35] Single center experience with tolvaptan in nine patients with autosomal dominant polycystic kidney disease (ADPKD)
    Hess, Nina
    Pollock, Emily
    Scharer, Verena
    Kobel, Claudia
    Weber, Nina
    Ritter, Alexander
    Mueller, Thomas
    Wuthrich, Rudolf P.
    Lorenzen, Johan
    SWISS MEDICAL WEEKLY, 2017, 147 : 13S - 13S
  • [36] EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE-STAGE CKD
    Hattanda, Fumihiko
    Makita, Minoru
    Takeda, Sayo
    Watanabe, Kanako
    Kawashima, Keisuke
    Kondo, Keiichi
    Ishikawa, Yozou
    Kusunoki, Yoshihiro
    Ishikawa, Yasunobu
    Nishio, Saori
    Atsumi, Tatsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 106 - 106
  • [37] Evaluating the safety and effectiveness of Tolvaptan for management of adult Korean ADPKD patients (ESSENTIAL study): final report
    Kim, Yong Chul
    Park, Hayne Cho
    Kim, Hyunsuk
    Kim, Yaerim
    Kim, Yong-Soo
    Jung, Yeonsoon
    Yoo, Tae-Hyun
    Na, Ki Young
    Kim, Yeong Hoon
    Kim, Sung Gyun
    Ahn, Curie
    Oh, Yun Kyu
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1968 - I1968
  • [38] Evaluating the safety and effectiveness of Tolvaptan for management of adult Korean ADPKD patients (ESSENTIAL study): final report
    Kim, Yong Chul
    Park, Hayne Cho
    Kim, Hyunsuk
    Kim, Yaerim
    Kim, Yong-Soo
    Jung, Yeonsoon
    Yoo, Tae-Hyun
    Na, Ki Young
    Kim, Yeong Hoon
    Kim, Sung Gyun
    Ahn, Curie
    Oh, Yun Kyu
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [39] Number Needed to Harm (NNH) Analysis of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Nunna, Sasikiran
    Betts, Keith A.
    Kumar, Retesh K.
    Nie, Xiaoyu
    Fernandes, Ancilla
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 161 - 161
  • [40] A POST HOC ANALYSIS OF STATIN USE IN TOLVAPTAN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PIVOTAL TRIALS
    Shoaf, Susan E.
    Ouyang, John
    Sergeyeva, Olga
    Estilo, Alvin
    Li, Hui
    Leung, Deborah
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 734 - 735
12345